Company / Interest Expense
AtriCure, Inc. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$6.9M
FY2023
5-year range
$4.9M / $6.9M
FY2019-FY2023
Trend
+38.9%
vs FY2022
Sector context
#35 of 40
Health Care
What the data says
AtriCure, Inc.'s interest expense of $7M is lower than 87% of companies in the Health Care sector (FY2023). Interest Expense has increased for 4 consecutive years, from $4M in FY2019 to $7M in FY2023.
Based on SEC 10-K filings.
$7M in FY2023 with a 5-year CAGR of +8.5%.
Increased from $5M to $7M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +12.3%
- 5-Year CAGR
- +8.5%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 40This company $6.9M Sector average $332.7M
▼
-97.9% below sector average
Key checks
Key Insights
- AtriCure, Inc.'s interest expense has grown for 4 consecutive years.
- 5-year CAGR of +8.5%, indicating consistent growth.
- In FY2023, interest expense increased 38.9% year-over-year.
- Ranks #35 out of 40 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -9.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $6.9M | +38.9% |
| FY2022 | $5.0M | +1.4% |
| FY2021 | $4.9M | +0.7% |
| FY2020 | $4.9M | +18.8% |
| FY2019 | $4.1M | -10.8% |
| FY2018 | $4.6M | +103.5% |
| FY2017 | $2.3M | +25.7% |
| FY2016 | $1.8M | +516.8% |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026